相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antisense drug discovery and development technology considered in a pharmacological context
Stanley T. Crooke et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia
PadmaKumar Narayanan et al.
NUCLEIC ACID THERAPEUTICS (2020)
High-content, label-free analysis of proplatelet production from megakaryocytes
Shauna L. French et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: Elucidating potential anti-atherothrombotic targets in obesity
Maria N. Barrachina et al.
ATHEROSCLEROSIS (2019)
Fostamatinib for the treatment of chronic immune thrombocytopenia
Nathan T. Connell et al.
BLOOD (2019)
Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis
Veena Mathew et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Functional significance of the platelet immune receptors GPVI and CLEC-2
Julie Rayes et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Characterization of the interactions of chemically-modified therapeutic nucleic acids with plasma proteins using a fluorescence polarization assay
Hans J. Gaus et al.
NUCLEIC ACIDS RESEARCH (2019)
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
E. Mercuri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Not all light transmission aggregation assays are created equal: qualitative differences between light transmission and 96-well plate aggregometry
Melissa V. Chan et al.
PLATELETS (2018)
Investigation into the Mechanism(s) That Leads to Platelet Decreases in Cynomolgus Monkeys During Administration of ISIS 104838, a 2′-MOE-Modified Antisense Oligonucleotide
Padmakumar Narayanan et al.
TOXICOLOGICAL SCIENCES (2018)
In vitro culture of murine megakaryocytes from fetal liver-derived hematopoietic stem cells
Prakrith Vijey et al.
PLATELETS (2018)
Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases
Kathleen M. Schoch et al.
NEURON (2017)
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
R. S. Finkel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Assessment of the Effects of 2'-Methoxyethyl Antisense Oligonucleotides on Platelet Count in Cynomolgus Nonhuman Primates
Scott P. Henry et al.
NUCLEIC ACID THERAPEUTICS (2017)
The Effects of 2′-O-Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials
Stanley T. Crooke et al.
NUCLEIC ACID THERAPEUTICS (2017)
The Interaction of Selectins and PSGL-1 as a Key Component in Thrombus Formation and Cancer Progression
Janos Kappelmayer et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Assessing single-stranded oligonucleotide drug-induced effects in vitro reveals key risk factors for thrombocytopenia
Sabine Sewing et al.
PLOS ONE (2017)
Safety of antisense oligonucleotide and siRNA-based therapeutics
Xuan Chi et al.
DRUG DISCOVERY TODAY (2017)
Synthesis and dephosphorylation of MARCKS in the late stages of megakaryocyte maturation drive proplatelet formation
K. R. Machlus et al.
BLOOD (2016)
Clinical and Preclinical Pharmacokinetics and Pharmacodynamics of Mipomersen (Kynamro®): A Second-Generation Antisense Oligonucleotide Inhibitor of Apolipoprotein B
Richard S. Geary et al.
CLINICAL PHARMACOKINETICS (2015)
Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators
Ulrike Flierl et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
The role of platelets in the recruitment of leukocytes during vascular disease
G. Ed Rainger et al.
PLATELETS (2015)
Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis
Milka Koupenova et al.
BLOOD (2014)
Clinical pharmacokinetics of second generation antisense oligonucleotides
Rosie Z. Yu et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice
Francisca Ferrer-Marin et al.
TRANSFUSION (2013)
High-content live-cell imaging assay used to establish mechanism of trastuzumab emtansine (T-DM1)-mediated inhibition of platelet production
Jonathan N. Thon et al.
BLOOD (2012)
The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL
Yury I. Miller et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
C. Frank Bennett et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and β2 integrin-dependent cell clearance program
Norma Maugeri et al.
BLOOD (2009)
Current concepts - Drug-induced immune thrombocytopenia
Richard H. Aster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Src and Syk kinases:: key regulators of phagocytic cell activation
G Berton et al.
TRENDS IN IMMUNOLOGY (2005)
Phase I trial of ISIS 104838, a 2′-methoxyethyl modified antisense oligonucleotide targeting tumor necrosis factor-α
KL Sewell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Variation in human platelet glycoprotein VI content modulates glycoprotein VI-specific prothrombinase activity
K Furihata et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
分享论文
